What’s Next For Teladoc Stock After An 89% Fall In Three Years?

Despite a 5% year-to-date fall in Teladoc stock (NASDAQ
NDAQ
: TDOC), a telemedicine and virtual healthcare company, underperforming the broader S&P500 index returns, of up 16%, we believe it is better avoided. Looking at a slightly longer term, TDOC stock is down 89% from levels seen in late 2020. This can be attributed to 1. the company’s P/S ratio falling 95% to 1.5x trailing revenues versus 30.9x in 2020, partly offset by 2. a 126% rise in Teladoc’s revenue to $2.5 billion, and 3. a 3% fall in its average total shares outstanding to 164 million. Our dashboard on Why Teladoc Stock Moved has more details.

ADVERTISEMENT